Connected Insights harnesses extensive knowledge sources via powerful API-integrations for streamlined variant interpretation, including prioritization of relevant clinical trials, drug labels, and guidelines. User-defined control of the workflow enables a flexible and automatable path for reporting. Connected Insights helps you address the interpretation bottleneck and move precision medicine forward.
Harness the power of API-integrated knowledge sources into a single solution to bring insights to diverse applications. Customize your analysis settings, then automate to go faster.
Remove unnecessary touchpoints and manual data movement for your NGS workflow. Seamless and secure, upstream and downstream.
Keep pace with comprehensive test options that enable diverse variant and biomarker analyses. Expand test menus and scale volume without increasing headcount and interpretation resources.
Generate insights from 45+ knowledge sources via a single interface via API-calling.
Grow and manage your lab's private curated knowledge.
Configure assays in your lab's SOP for fast automation and scale.
Evolve with confidence, ensuring compatibility with a wide range of assay types—panels, exomes, genomes, and beyond.
Reflect regional and lab-specific practices for guidelines, clinical trial availability, and more in the user-defined data interpretation flow.
Ensure data security, privacy, and compliance are in check across the entire workflow.
Identify key DNA variant types (SVs, MNVs, exon-level CNVs, indels, fusions, tandem repeats, LOH) relevant in multiple disease types and across a variety of NGS assays.
Analyze variants from RNA or transcriptomics (fusions, splice variants, and soon expression levels) to gain a deeper and more comprehensive understanding of malignancies.
Uncover more insights by interpreting genome- wide, pan-cancer biomarker signatures (TMB, MSI, HRD) with increasing relevance to precision medicine.
Prepare libraries for somatic oncology panels or other compatible applications.
Sequence libraries using any Illumina or other sequencing platform.
Call variants with DRAGEN or other secondary analysis tools to generate VCF (Variant Call Format) output.
Input VCF files to Connected Insights to enable generation of insights and case reporting.
To meet the most stringent security requirements, Illumina Connected Insights platform is built with security and compliance at its core. Read the security brief for more details.
Configure once with a fine level of granularity to match your lab’s standard operating procedure (SOP). Accelerate your workflow with automation and standardization according to your SOP.
Grow your lab’s private knowledge base with every case and instantly interpret cases against your historical experience. Your curated knowledge is private, secure, and always at your fingertips.
Customize based on lab name, lab branding, sections, fields, and more. Move sections and add or delete sections. Easily edit reports without data reingestion.
Quickly view key findings, coverage, and quality in a consolidated format. Intuitively access deeper evidence sources with a streamlined user interface design.
Control variant filters using extensive available options to match your exact SOP. Accelerate case turnaround time with efficient review and variant triage.
Easily filter and sort for variant prioritization for your case. Maximize efficiency by focusing on variants that are most likely to be associated with a disease or condition.
Stay focused on up-to-date and comprehensive variant-related details. Consolidate variant insights into assertions with full editing options and customizable outputs for your reports.
Discover how Connected Insights can streamline data interpretation and reduce the time it takes to generate reports through a single-vendor workflow.
Watch this video to understand how Connected Insights can connect various knowledge sources to streamline data interpretation operations for critical insights.
Read how Connected Insights streamlines, integrates, and powers molecular pathology laboratories for scale and growth.
Key opinion leaders discuss the ongoing challenges and future potential of NGS in clinical oncology.
Comprehensive genomic profiling (CGP) uses a single assay to assess hundreds of genes including relevant cancer biomarkers, as established in guidelines and clinical trials, for therapy guidance.
Focus on sequencing coding regions, which frequently contain mutations that affect tumor progression, for a cost-effective approach.
Laboratory information management system that helps genomics labs track samples and manage workflows for an optimized and efficient lab.
The Illumina DRAGEN Bio-IT platform provides accurate, comprehensive, and efficient analysis of next-generation sequencing data.